Mpox vaccine maker Bavarian Nordic seeks ‘critical’ EU approval for teens after WHO declares health emergency
Publishing timestamp: 2024-08-16 12:45:30
Summary
Danish biotech company Bavarian Nordic has submitted data to extend the use of its mpox vaccine for teenagers in response to the escalating outbreak of a new strain of the virus in Africa. The World Health Organization declared a public health emergency, and the company's stock price rallied as demand for the vaccine increased. Bavarian Nordic is ready to ship doses to countries in need, but bottlenecks in Africa have hindered distribution. The company is urging greater international cooperation to ensure doses reach those most in need.
Sentiment: MIXED
Keywords: biotechnology, pharmaceuticals, biotech and pharmaceuticals, bavarian nordic a/s, business news, health care industry,